Lecture Theatre 2, Hudson Beare
Micro and Nanotechnologies for Advanced Drug Delivery Systems
The market for advanced drug delivery systems is rising rapidly, because many new medicines rely on novel and innovative delivery techniques, and the improvement of delivery platforms can as well promote existing drugs’ therapeutic efficacy, alleviate their side effects, and reduce the cost, etc. Here I would like to introduce our research development in innovating and improving drug delivery and bioimaging based on micro and nanotechnologies, including microneedle arrays for painless and efficient transdermal vaccination, nanoneedle arrays for high-throughput intracellular delivery, and nanomaterials for enhanced cancer therapy and tumour imaging.
Michael Xianfeng Chen received his PhD in Materials Science from University of Oxford in 2007. He then worked in Australian Institute for Bioengineering and Nanotechnology at The University of Queensland first as a postdoc and then research fellow for four years. Since March 2011, he has been assistant professor and lecturer at the City University of Hong Kong and University of Bradford, respectively. He joined in the Institute for Bioengineering in the School of Engineering on the 1st of June 2016. He is working in Chemical Engineering discipline within the school. Dr Chen’s research is focused on biomaterials, biomedical engineering, and the application of nanomaterials in biology and medicine. He has published over 70 peer-reviewed journal articles and 2 book chapters. Additionally, he holds 7 patent families in drug delivery technologies (including 27 patent applications in major countries/regions including USA and Europe). Some of these technologies have been invested by venture companies for commercialisation and also licenced to Merck & Co., Inc.